U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07034781) titled 'A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults' on June 12.
Brief Summary: To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Type2 Diabetes Mellitus
Intervention:
DRUG: Comparator 1
Dapagliflozin 10mg + Linagliptin 5mg
DRUG: Comparator 2
Metformin 1000mg
DRUG: Test Drug
Fixed-dose combination tablet (AJU-A53)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AJU Pharm Co., Ltd.
Published by HT Digital Content Services with permissio...